Share this Post!

The Food and Drug Administration (FDA) informs all healthcare professionals and the public that the medical device product “Nexcare First Aid Opticlude™ Orthoptic Eye Patch” has been notified by the Market Authorization Holder (MAH), 3M Philippines Inc., with FDA notification number CDRRHR-CMDN-2021-756258 in accordance to FDA rules and regulations

Accordingly, the warning against the purchase and use of the product as mentioned in FDA Advisory No. 2021-0349 is hereby lifted.

For more information and inquiries, kindly contact the FDA Center for Device Regulation, Radiation Health, and Research through email at [email protected], or call (02) 8857-1900 loc. 8301.

To report any sale or distribution of unregistered medical device products, the online reporting facility, eReport can be accessed at www.fda.gov.ph/ereport.

The issuance of this advisory shall not in any manner preclude this Office from issuing subsequent orders it may deem necessary and appropriate, should there be findings of any violation of the company to the existing laws, rules and regulations.

Dissemination of this advisory to all concerned is hereby requested.

Attachments